| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |